To define the relationship between ADAR2 and miR-34a in NAFLD, we found that ADAR2 can negatively regulate the expression of miR-34a in vitro, regardless of OA treatment. The gene discussed is ADARB1; the disease is metabolic dysfunction-associated steatotic liver disease.